The FDA has approved FoundationOne Liquid CDx as a companion diagnostic for patients with metastatic non–small cell lung ...

FoundationOne Liquid CDx is now FDA-approved to identify mNSCLC patients with MET exon 14 skipping alterations for tepotinib ...

In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...

BofA lowered the firm’s price target on PepGen (PEPG) to $6 from $10 and keeps a Neutral rating on the shares after the company announced several changes to the eligibility criteria for the 10mg/kg ...

NEW YORK – Roche subsidiary Foundation Medicine said on Monday that its FoundationOne Liquid CDx assay has received approval from the US Food and Drug Administration for use as a companion diagnostic ...

Mutual of America Capital Management LLC cut its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) ...

Aigen Investment Management LP reduced its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 81 ...

FDA 已批准 FoundationOne Liquid CDx 作为伴随诊断试剂，用于识别患有MET外显子 14 跳跃变异的转移性 NSCLC 患者。此项批准将帮助临床医生识别可能受益于特泊替尼 (Tepmetko) ...

Figure 1: AZFa region of the human Y chromosome. Figure 2: De novo deletion at USP9Y splice-donor site in azoospermic man WHT2780.

MIAMI, FL -- The former Federal Emergency Management Agency employee who was fired earlier this month after being accused of skipping homes of Donald Trump supporters while providing relief in ...

Welcome to the CRG Bioinformatics Core GitHub! We provide researchers with services of analyses of high-throughput sequencing (NGS, Nanopore, droplet-based) and other biomedical data, ...